hemodialysis
Procedurevarying concentration of glucose in dialysate
NCT Number: NCT00618033
This study aims to show that using a glucose (sugar) concentration of 100 mg/dL in the dialysis fluid for hemodialysis is not inferior to using a concentration of 200 mg/dL with regard to the frequency and magnitude of blood glucose drops. Other parameters that will be compared between the two groups are blood pressure, heart rhythm, weight gain between dialysis treatments, and fatigue after the treatment.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Irving Place Dialysis Center, New York, United States
This is a prospective, randomized, single-blinded cross-over non-inferiority trial of intra- and early post-dialytic glucose homeostasis comparing 100 mg/dL against 200 mg/dL dialysate glucose concentration in 30 hemodialysis patients. The primary outcome is the frequency and magnitude of hypoglycemia during and early after the hemodialysis treatment. Secondary outcomes include intradialytic blood pressure, interdialytic weight gain, serum potassium and phosphorus concentrations, arrhythmias during dialysis and in the early postdialytic period, and postdialytic fatigue.
Inclusion criteria
Age ≥ 18 years
Maintenance hemodialysis with hemodialysis vintage of at least 30 days
Ability to read and understand the English language and give informed consent
Exclusion criteria
Dialysis treatment frequencies other than three times per week
Hospitalizations or antibiotics-dependent infection during the 8 weeks preceding enrollment
Central venous catheter as hemodialysis access
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
varying concentration of glucose in dialysate
Time frame: 6 weeks
Time frame: 6 weeks
Renal Research Institute
Other
Short-Term Study of Physiologic Dialysate Glucose Concentration in Chronic Hemodialysis Patients
Acronym: Dextrose
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06466421
Chronic Disease, Chronic Kidney Disease-associated Pruritus
Tanta, Elgharbia, Egypt
View Trial DetailsNCT00850252
Chronic Disease, Disease Attributes
Buenos Aires, Argentina
View Trial DetailsNCT07687498
Chronic Disease, Disease Attributes
Mersin, Yenişehir, Turkey (Türkiye)
View Trial DetailsNCT04877041
Chronic Disease, Disease Attributes
Adelaide, South Australia, Australia
View Trial Details